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Abstract
Zn is an essential nutrient that is required in humans and animals for many physiological functions, including immune and antioxidant function, 
growth, and reproduction. The present study evaluated whether Zn deficiency would negatively affect bone-related enzyme, ALP, and other bone-related
minerals (Ca, P and Mg) in rats. Thirty Sprague Dawley rats were assigned to one of the three different Zn dietary groups, such as Zn adequate
(ZA, 35 mg/kg), pair fed (PF, 35 mg/kg), Zn deficient (ZD, 1 mg/kg) diet, and fed for 10 weeks. Food intake and body weight were measured
daily and weekly, respectively. ALP was measured by spectrophotometry and mineral contents were measured by inductively coupled plasma- mass
spectrophotometer (ICP-MS). Zn deficient rats showed decreased food intake and body weight compared with Zn adequate rats (p<0.05). Zn deficiency
reduced ALP activity in blood (RBC, plasma) and the tissues (liver, kidney and small intestine) (p<0.05). Also, Zn deficiency reduced mineral
concentrations in rat tissues (Ca for muscle and liver, and Mg for muscle and liver) (p<0.05). The study results imply the requirement of proper
Zn nurture for maintaining bone growth and formation. 
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Introduction6)
The major Zn deficiency in experimental animals and to lesser 
extent in human is associated with skeletal and growth retardation 
due to anorexia, weight loss and poor food efficiency (Vallee 
& Falchuk, 1993). Rats fed with a Zn-deficient diet consume 
less food and therefore have significantly reduced growth which 
has been associated with abnormalities in bone growth, bone 
formation and mineralization (Roth, 2003; Yamaguchi & Yama-
guchi, 1986). In addition, Zn deficiency weakens protein syn-
thesis (Giugiano & Millward, 1987), making Zn an essential 
factor for the synthesis of proteins (Hendy et al., 2001). Also, 
Zn is known to be necessary for normal collagen synthesis and 
mineralization of bone that has been demonstrated to be essential 
for normal growth of both human and animal skeletal systems 
(Bougle et al., 2004; Doherty et al., 2002; Eberle et al., 1999; 
Elmstachl et al., 1998; Hosea et al., 2004; Hyun et al., 2004; 
Ovesen et al., 2001; Peretz et al., 2001; Rossi et al., 2001; Seco 
et al., 1998; Suwarnasarn et al., 1982;). It therefore has been 
considered that Zn can be a critical factor to affect skeletal 
development and bone formation. However, it has not been 
clearly clarified how Zn controls bone formation, yet. 
Bone formation is regulated through bone remodeling (Karsdal 
et al., 2007). Bone remodeling is comprised of two well defined 
cellular events that occur sequentially. There is first the resorption 
of preexisting bone by the osteoclasts then de novo bone 
formation by the osteoblasts (Ducy et al., 2000; Frost, 1969). 
Osteoporosis, a bone remodeling disease, is the most common 
bone disease (Sambrook & Cooper, 2006) and a lot of efforts 
are being made to clarify that particular disease at menopause. 
The coordination of bone remodeling to maintain bone mass can 
be affected by Zn. Zn stimulates bone metabolism in rats and 
bone formation in tissue cultures by increasing bone DNA and 
protein synthesis (Yamaguchi & Yamaguchi, 1986; Yamaguchi 
et al., 1988). In addition, Zn was shown to exert an inhibitory 
effect on the activity of the osteoclasts responsible for bone 
resorption in vitro (Holloway et al., 1996; Moonga & Dempster, 
1995). In the recent study, overexpression of the ZIP1, ubiquitous 
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zinc transporter in the cells, induces an osteogenic phenotype 
in human mesenchymal stem cells (MSCs) through increasing 
osteoblast differentiation genes, including bone-specific zinc 
finger transcription factor Cbfa1/Runx2 and alkaline phosphatase 
(ALP) (Tang et al., 2006). This report investigated osteogenic 
Zn function on the bone formation at cellular and molecular level.
Alkaline phosphatase (ALP) is an enzyme which is synthesized 
by the liver, bone, and less amount by intestines and kidney. 
As the name implies, this enzyme works best at an alkaline pH 
(pH ≥10), and thus the enzyme itself is inactive in the blood. 
ALP removes phosphate group (known as dephosphorylation) 
from many types of molecules, including nucleotides, proteins, 
and alkaloids. For Ca crystallization on bone formation, Ca can 
be crystallized in an alkaline environment, but dissolved in an 
acidic state (Shinozaki & Pritzker, 1996). Alkaline phosphatase 
is synthesized and secreted by osteoblasts during the maturation 
of osteoblast phenotypic period, three consecutive phases of 
proliferation, extracellular matrix maturation and mineralization 
(Stein & Lian, 1993), in bone tissue. Thus it makes sense that 
osteoblasts synthesize and secrete alkaline phosphates creating 
a local bone environment of alkalinity by splitting off phosphorus 
(an acidic mineral) creating an alkaline pH to help build bone 
Ca mineralization. ALP is normally presents in high concen-
trations in growing bones and it is also known as Zn-dependent 
enzyme. 
The present study investigated the effects of Zn deficiency on 
ALP, which stimulates extracellular matrix Ca mineralization and 
minerals (Ca, Mg and P), which are the ECM components of 
Ca mineralization in rats. To avoid the effect of the decreased 
food intake which is the major sign of Zn deficiency, we also 
designed the experiment to pair-fed the rats the normal 
Zn-adequate diet with the decreased amount of Zn-deficient 
dietary group. Again, the study aims to elucidate the ALP and 
trace minerals (Ca, Mg and P) in blood and various tissues of 
Zn-deficient rats. 
Materials and Methods
Animals and diets
Thirty Sprague Dawley rats (100 g, 4 weeks of age) were 
obtained from SLC Inc, (Shizuoka, Japan), and were individually 
housed in stainless steel wire-bottom cages in an environmentally 
temperature controlled room at 22 ± 0.5℃ with an alternate 12 
h light and dark cycle. The rats were grouped into one of the 
three Zn dietary groups (Zn-adequate, ZA; pair-fed, PF; and 
Zn-deficient group, ZD. n=10 per group) and were given a 
modified egg albumin-based AIN-76 diet that contained modified 
mineral mixture (Harlan Tekland, Wisconsin USA) provided with 
35 and 1 mg Zn/kg diet for ZA and ZD diets, respectively, as 
previously described (Kwun et al., 2007; Lee et al., 2003). To 
control for reductions in food intake that characteristically occur 
in ZD rats, a PF group was fed the same amount of ZA food 
eaten by ZD rats. All rats had free access to distilled and 
deionized water from plastic bottles with silicon stoppers. ZA 
and ZD rats were given free access to food.
The diet was stored at 4℃ in plastic containers and handled 
with plastic gloves and appropriate utensils to avoid Zn 
contamination. Food intake was recorded daily and body weight 
was recorded every week. The care and use of the rats strictly 
followed “The Guiding Principles for the Care and Use of 
Animals” (National Research Council, 1996) and the ANU 
institutional guidelines. To ensure that the rats would be given 
appropriate amounts of Zn, the diets were analyzed using 
inductively coupled plasma spectrophotometer (ICP; Flame 
Modula S, Germany). Samples were digested using nitric acid 
(Fluka, Switzerland) and diluted with trace element free 0.125 
M HCl (Fluka, Switzerland) at 1:10. Analyzed Zn concentration 
of the diets showed that the nominal Zn concentration agreed 
with the actual Zn concentration having 0.3 ± 0.1 mg/kg feed 
for Zn-deficient and 35.1 ± 12.9 mg/kg feed for both ZA and 
PF diets. Zn deficiency took place with a Zn intake of <1 mg 
Zn/kg (Chesters & Quarterman, 1970; Scrimgeour et al., 2007). 
The analytical accuracy of the method for mineral analysis was 
tested using a standard reference material (SRM) obtained from 
National Institute of Standards and Technology (NIST SRM 
1577b, bovine liver, USA) and the recovery of Zn was 97.3 ±
8.0%. 
Blood and tissue collection
On the last day of dietary Zn treatment for ZA and ZD groups, 
and one day later for the PF group, the assigned rats were 
anesthetized with ketamin/HCl (10 mg/kg body weight). Blood 
sample was obtained from the abdominal aorta using a hepari-
nised syringe and centrifuged at 10,000 × g for 15 min to obtain 
plasma and red blood cells. The tissues [liver, muscle, kidney, 
small intestine (SI) and white adipose tissue (WAT)] were 
collected for ALP, Zn and minerals (Ca, Mg, and P) 
determination. The tissue and plasma samples were then 
snap-frozen in liquid nitrogen and stored at -80℃. 
Tissue and blood alkaline phosphatase (ALP) activity assay 
Tissues (liver, muscle, kidney, SI) and blood (plasma and red 
blood cell) alkaline phosphatase were measured by enzymatic 
activity. Tissues and RBCs were washed with PBS and 
homogenized in 1 mL of 0.25 M sucrose (Sigma, USA) on ice. 
The cytosol was centrifuged for 15 min at 12,000 × g. The 
supernatant was kept at -20℃ until analysis. The ALP activity 
in cytosol of tissues, RBCs and plasma was measured by using 
p-nitrophenyl phosphate as the substrate. In brief, aliquots of 
tissue homogenates and RBCs and plasma were mixed with assay 
buffer containing 10 mM p-nitrophenyl phosphate in 0.1 M 
sodium carbonate buffer, pH 10, supplemented with 1 mM MgCl2 Young-Eun Cho et al. 115
Table 1. Daily food intake and body weight of the rats during the whole experimental period (42 d) by dietary zinc level
1
Food intake Body weight
Day ZA PF ZD ZA PF ZD
0 14.5 ± 0.2 14.9 ± 0.3 14.4 ± 0.6 120.1 ± 2.6 120.5 ± 2.4 120.6 ± 2.4
7 14.8 ± 0.3 15.3 ± 0.4 15.3 ± 0.5 152.2 ± 1.9 143.8 ± 2.8 150.1 ± 2.5
14 17.0 ± 0.3
a 13.9 ± 0.6
b 11.0 ± 0.7
c 204.4 ± 2.7 197.1 ± 2.9 200.2 ± 3.4
21 18.9 ± 0.4
a 13.2 ± 1.4
b 10.3 ± 1.3
b 253.0 ± 3.1
a 210.3 ± 2.8
b 207.9 ± 3.0
b
28 19.8 ± 0.6
a 11.0 ± 1.5
b 12.3 ± 1.7
b 298.3 ± 4.2
a 220.7 ± 2.0
b 211.7 ± 2.7
b
35 19.0 ± 0.9
a 10.4 ± 0.9
b 11.4 ± 1.2
b 328.8 ± 4.6
a 227.8 ± 2.8
b 216.1 ± 1.7
c
42 18.3 ± 0.4
a 10.1 ± 1.7
b  9.5 ± 0.9
b 347.8 ± 5.2
a 225.0 ± 3.9
b 219.7 ± 2.5
b
1 Values are mean ± SE (n=10 per group). ZA (Zn-adequate, 35 mg Zn/kg diet), PF (pair-fed, 35 mg Zn/kg diet) and ZD (Zn-deficient, 1 mg Zn/kg diet). Daily food intake 
and weekly body weight were measured. Different superscripts mean significantly different among Zn dietary group at p＜0.05 by  Tukey, one-way ANOVA within each 
food  intake  or  body  weight.
Fig. 1. Activity of alkaline phosphatase (ALP) in red blood cell (RBCs, A) and 
plasma (B) of Zn-adequate (ZA), pair-fed (PF) and Zn-deficient (ZD) rats. 
V a l u e s  a r e  m e a n±S E  ( n = 7  p e r  f o r  R B C s ;  n = 7  f o r  Z A  a n d  P F ,  n = 5  f or  ZD  for 
plasma). Different superscripts mean significantly different among Zn dietary group 
at p <0.05 by Tukey, one-way ANOVA. One unit of ALP activity is expressed as 
the  amount  of  p-nitrophenol  phosphate  as  products  being  converted  from 
p-nitrophenyl phosphate as substrate for 30 minute reaction time (RBCs ALP 1 unit 
= 1 nmole p-nitrophenol phosphate/30 min/mg protein ; p lasm a ALP 1 unit = 1 
nmole p - nitrophenol  phosphate/30  min/ml)
and followed by an incubation at 37℃ for 30 min. After adding 
1 M NaOH, the amounts of p-nitrophenol liberated in the assay 
mixtures were measured using a spectrophotometer at 420 nm. 
(unit; mmoles/min/mg protein or mU/mg protein) (Bessey et al., 
1946). Plasma ALP activity was expressed as p-nitrophenol 
phosphate nmole /ml/30 mins as 1 unit. Protein concentration 
of tissues and RBCs was estimated by the method of Lowry et 
al. (1951) with bovine serum albumin (BSA) as the substandard.
Tissue Zn and other mineral (Ca, Mg and P) analysis 
Tissues (liver, muscle, kidney, SI and WAT) in trace element 
free 0.125 M HCl were homogenized before trace mineral assay. 
Tissues were dried and ashed at 500℃ in furnace for overnight. 
Tissues were wet digested using concentrated nitric acid and 
diluted with trace element free 0.125 M HCl at 1:2 to 1:30 as 
appropriate. The diluted samples were filtered using 0.2 μm 
syringe filter (Corning, USA) and measured using inductively 
coupled plasma spectrophotometer (ICP; Flame Modula S, 
Germany) for Zn, Ca, Mg and P. Protein concentration in tissues 
was analyzed by Lowry method.
Statistical analysis 
The data were expressed as means ± SE and analyzed using 
SPSS program. Differences were considered significant at 
p<0.05. Statistical analysis of the data was performed by one-way 
ANOVA followed by Tukey post hoc test to test the significance 
in the effect of different Zn dietary groups.
Results 
Body weight and food intake
Daily food intake and weekly body weight during the whole 
experimental period are shown in Table 1. Rats fed ZD diets 
consumed significantly less food than rats fed ZA diets since 
2
nd week of the experimental diet feeding (p<0.05). Also, rat 
consuming the ZD diets exhibited significantly lower body 
weight compared to PF or ZA (p<0.05). Mean body weight at 
the final 7
th week, ZA group (347.8 g) showed about 100 g higher 
body weight than that of PF (225.0 g) or ZD group (219.7 g).
Tissue and blood alkaline phosphatase (ALP) activity 
Alkaline phosphatase (ALP) activities in blood subfractions, 
as plasma and red blood cells (RBCs) during different dietary 
Zn periods (ZA, PF and ZD) are shown in Fig. 1. ALP activity 
in the plasma of the ZD rats was significantly decreased 
compared with the ZA rats (p<0.05). Also ALP activity in the 
RBCs showed the same pattern of plasma ALP activity even 
without significance.116 Zinc deficiency on bone enzyme ALP and minerals (Ca, Mg, and P) in rats
        
         
Fig. 2. Activity of alkaline phosphatase (ALP) in liver (A), muscle (B), kidney (C) and SI (small intestine, D) of Zn-adequate (ZA), pair-fed (PF) and Zn-deficient 
(ZD) rats. Values  are mean ± SE (n=8-10  per group). Different superscripts mean  significantly  different  among  Zn  dietary  group  at  p＜0.05  by  Tukey,  one-way  ANOVA. 
Tissue  ALP  1  unit = 1  nmole  p-nitrophenol  phosphate/30  min/mg  protein).
Table 2. Bone-related mineral (Ca, Mg and P) concentration in rat tissues (liver, muscle, kidney, small intestine and white adipose tissue) fed different dietary zinc
level
1 
Ca concentration (μg Ca/g dry tissue) P concentration (mg P/g dry tissue) Mg concentration (μg Mg/g dry tissue)
Tissues ZA PF ZD ZA PF ZD ZA PF ZD
Liver 121.9 ± 5.0
a 49.1 ± 6.8
b  68.0 ± 6.4
b 2.24 ± 0.17 2.57 ± 0.07 2.10 ± 0.20 153.0 ± 18.8 156.5 ± 16.8 112.1 ± 0.4
Muscle  61.7 ± 0.8
a 41.6 ± 3.0
b  44.4 ± 2.8
b 1.30 ± 0.52 1.26 ± 0.05 1.54 ± 0.14 188.3 ± 0.3
a 57.3 ± 9.4
b  48.5 ± 14.7
b
Kidney  122.0 ± 12.0
a  98.9 ± 15.3
b 104.5 ± 2.2
b 2.15 ± 0.15 2.15 ± 0.28 2.25 ± 0.05 191.6 ± 17.4 184.6 ± 19.9 186.0 ± 4.2
Small intestine  132.7 ± 16.2
a 94.2 ± 7.6
ab  83.3 ± 8.6
b 1.65 ± 0.20 1.38 ± 0.11 1.30 ± 0.13 140.2 ± 9.1
a 105.2 ± 8.1
ab  87.3 ± 11.6
b
White adipose 
tissue  27.7 ± 3.2
b 44.8 ± 4.2
a  25.2 ± 2.3
b 0.18 ± 0.03
b 0.54 ± 0.11
a 0.22 ± 0.04
b 25.3 ± 4.7
b 42.5 ± 6.5
a 22.5 ± 5.3
b
1  Values are means ± SE (n=3-4 per group). ZA (Zn-adequate, 35 mg Zn/kg diet), PF (pair-fed, 35 mg Zn/kg diet) and ZD (Zn-deficient, 1 mg Zn/kg diet). Different superscripts 
mean  significantly  different  among  Zn  dietary  group  at  p<0.05  by  Tukey,  one-way  ANOVA.
ALP activity in tissues, as liver, muscle, kidney and SI by 
different dietary Zn groups (ZA, PF and ZD) are shown in Fig. 
2. ALP activity in liver, kidney and SI of the ZD rats was 
significantly lower than that of ZA or PF rats (p<0.05), however 
ALP activity in tissues, as liver, kidney and SI between ZA and 
PF was not different. ALP activity in the muscle showed the 
same pattern without significance. In this study, ALP activities 
both in tissues (liver, kidney and SI) and plasma of ZD rats were 
decreased compared with the ZA rats.
Tissue Zn concentration
Zn concentrations in tissues, as liver, muscle, kidney, SI and 
WAT by different dietary Zn levels (ZA, PF and ZD) are shown 
in Fig. 3. Dietary Zn did not affect the Zn concentration in tissues 
such as liver, muscle and kidney. Zn concentration in SI of ZD 
rats was decreased compare to ZA or PF controls (p<0.05). 
Unexpectedly, Zn concentration in WAT of PF rats was higher 
than that of ZA or ZD (p<0.05).
Tissue mineral (Ca, P and Mg) concentration
Ca concentration in tissues, as liver, muscle, kidney, SI, and 
WAT by different dietary Zn levels (ZA, PF and ZD) are shown 
in Table 2. Ca concentration in tissues showed consistent pattern 
depending on different dietary Zn periods. Ca concentrations in 
liver, muscle and SI of ZD rats were significantly lower than 
those in ZA rats (p<0.05). However Ca concentration in WAT 
of PF rats was increased compared with ZA and ZD (p<0.05), 
as the pattern was the same for WAT Zn concentration. P 
concentration in tissues did not differ by dietary Zn groups among 
ZA, PF and ZD rats, except WA tissue. Mg concentrations were 
decreased in muscle and SI (p<0.05) of ZD group. Zn and all 
other minerals (Ca, P and Mg) were increased in PF group 
compared with ZA or ZD. In tissues, ZD rats had lower mineral 
concentrations (Zn, Ca, Mg and P) than ZA rats, respectively. 
However, Zn, Ca, Mg and P concentrations in WAT of PF rats 
were significantly increased compared with ZA and ZD (p<0.05). 
It suggests that further studies on how dietary Zn level affects 
WAT in rats are needed.Young-Eun Cho et al. 117
Fig. 3. Zn concentration in liver (A), muscle (B), kidney (C), SI (small 
intestine, D) and WAT (white adipose tissue, E) of Zn-adequate (ZA), 
pair-fed (PF) and Zn-deficient (ZD) rats. Values are mean ± SE (n=3-4 per 
group).  Different  superscripts  mean  significantly  different  among  Zn  dietary 
group  at  p＜0.05  by  Tukey,  one-way  ANOVA
Discussion 
The study aimed that Zn deficiency decreases ALP and 
bone-related major minerals (Ca, Mg and P) in rats. Thus, the 
present study investigated the effects of dietary Zn deficiency 
on food intake, body weight following the patterns of bone 
formation enzyme (ALP) and bone related minerals (Ca, Mg, 
and P) in rats on the 6-week dietary Zn treatment. Many previous 
studies of Zn deficiency in rats have indicated that severely Zn 
deficient diets cause a decrease in body weight and bone growth 
due in part to decreased appetite and impaired protein synthesis 
(Eberle et al., 1999; Hosea et al., 2004; Rossi et al., 2001; 
Underwood, 1981). In the study conducted, generally, rats from 
all the feeding groups increased their body weights within the 
6-week feeding period. However, ZA group significantly 
increased the body weight including food intake as compared 
to the PF and Zn-deficient groups which strongly confirms 
previous claims that Zn deficiency slows down appetite 
regulation. Interestingly, food intake was not affected until seven 
days later which resulted from the casein-based diet as protein 
source until day 12. After then, the protein source was changed 
to egg white, which contains naturally less Zn compared to 
casein, to induce much severe Zn deficiency. Therefore, there 
might be a regulatory impulse generated and that Zn deficiency 
might have reached the critical level that induced the rats to stop 
eating since the egg white diet was fed. Hurley et al. (1982) 
showed that plasma Zn level of rats was dropped to 45% from 
the normal level after 8 h of consuming Zn-deficient diet. Even 
with the early drop of Zn level in rat plasma, food intake was 
still not affected until four days after which suggests a presence 
of some regulatory impulse triggered when Zn deficiency reached 
its critical level that induced the animal to stop eating. Regulatory 
impulse is more likely stimulated by a change in organ or tissue 
Zn concentration. 
Zn is an important part of about more than 200 metalloenzymes 
and thus participates in various molecular mechanisms at cellular 
level and in vivo system (Galdes & Vallee, 1983). The present 
study showed that ALP activity was decreased in plasma (p<0.05) 
of Zn-deficient rats compared with the ZA or PF controls. Also, 
ALP activities in the liver, kidney and SI were significantly 
decreased in Zn-deficient rats compared with ZA and PF group, 
as shown in the plasma (p<0.05). Actually, ALP in the plasma 
is the total amount of alkaline phosphatases released from the 
tissues such as liver, bone, kidney, intestinal layers and muscle 
etc, where ALP is synthesized, into the blood. Since no difference 
in ALP activity between ZA and PF group where food intake 
should be counted was shown, the decreased plasma ALP activity 
in Zn-deficient group can be accounted by Zn deficiency, not 
by decreased food intake. Alkaline phosphatase is a key enzyme 
for the formation and calcification of the bone tissues. The 
preosteoblasts differentiate into osteoblasts and then produce 
ALP, and process procollagens to collagens; and finally the cells 
form mineralized tissues in vitro. (Yamaguchi et al.,1986). The 
decreased blood and tissue ALP activity may be cautiously 118 Zinc deficiency on bone enzyme ALP and minerals (Ca, Mg, and P) in rats
interpreted as the potential risk for skeletal growth retardation 
in rats in the present study. 
The Zn concentration in soft tissues such as muscle, brain, 
liver and skin is not easily mobilized to be available for 
supporting important metabolic functions (ƠDell  et al., 1989; 
Roth, 2003). They reported that muscle and liver tissue could 
not draw upon for mobilization of a Zn deficiency. Our results 
also supported that tissue Zn level would be mobilized easily 
even under dietary Zn deficiency. In our study, dietary Zn 
deficiency did not affect tissue Zn concentration, such as liver, 
muscle and kidney (Fig. 3). Zn concentration in SI of Zn-deficient 
rats was significantly affected being lower than ZA rats (p<0.05). 
Ca, Mg and P are known as major minerals for bone formation 
and bone mineralization (Koshihara et al., 2005). We analyzed 
Ca, Mg and P concentration in tissues, such as liver, muscle, 
kidney, SI and WAT in rats (ZA, PF and ZD). Tissue Ca and 
Mg concentrations were dependent of dietary Zn level in this 
study. Ca concentration in tissues, such as liver, muscle, kidney 
and SI showed consistent pattern depending on different dietary 
Zn periods. Ca concentrations in liver, muscle and SI of 
Zn-deficient rats were significantly lower than those of ZA or 
PF controls (p<0.05) (Table 2). Also, kidney Ca concentration 
was decreased in Zn-deficient rats and unfortunately not shown 
to be significant. The dietary Zn deficiency of rats lowered Mg 
concentration more than the ZA rats. Mg concentrations in 
muscle and SI were significantly dependent on dietary Zn level 
in this study (Table 2). However, tissue P concentration was not 
different by dietary Zn groups. Therefore, it can be suggested 
that dietary Zn deficiency may decrease tissue Ca and Mg 
concentrations, which may affect negatively skeletal growth in 
rat model. One unexpected result in this study was that dietary 
Zn deficiency did not affect WAT Zn, Ca, P and Mg con-
centrations compared with ZA and ZD (p<0.05), rather Zn 
deficiency group showed lower level of Zn and these minerals, 
particularly in WA tissue. Further studies are needed to examine 
whether dietary Zn deficiency affects tissue-specific pattern or 
some other underlying regulation mechanism. In the present 
study, pair-fed group was only designed to control the effect of 
food intake on Zn intake of the Zn-deficient rats. Zn-deficient 
rats would definitely decrease their food intake and thus decrease 
Zn and other nutrient intake as well. Pair-fed group was only 
designed to eliminate this factor.
In summary, the present study demonstrated that ALP and bone 
related minerals (Ca, Mg and P) are affected by Zn deficiency 
independent of food intake or body weight. Clearly, rat model 
shows that Zn is essential to bone health that ALP of dietary 
ZD rats were significantly decreased in the plasma and minerals, 
Ca, Mg and P, in the various tissues (liver, muscle and SI) 
compared to dietary ZA rats. Thus, it can be suggested that 
dietary Zn deficiency negatively affects bone growth and bone 
formation in rats.
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